United Kingdom · Question · Written question
UIN 103740
Gabapentin: Research
Introduced
7 January 2026
Last action
13 January 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
13 January 2026
Summary
To ask the Secretary of State for Health and Social Care, whether research is being conducted into the potential association between Gabapentin use and the development of attentional amnestic disorders or other cognitive impairments.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
7 January 2026
Written question
To ask the Secretary of State for Health and Social Care, whether research is being conducted into the potential association between Gabapentin use and the development of attentional amnestic disorders or other cognitive impairments.
Source: Commons
13 January 2026
Answer
Gabapentin is authorised to treat epilepsy and peripheral neuropathic pain, or nerve pain. The known side effects of gabapentin are outlined in the product information, the Summary of Product Characteristics (SPC) for healthcare professionals, and the Pat...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-01-07/103740
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1868966
- uk · wq-1868966 · source updated 13 January 2026